News

Health on MSN19h
Zepbound or Wegovy? Head-to-Head Trial Says One Is Better for Weight Loss
Eli Lilly’s Zepbound proved more effective than Novo Nordisk’s Wegovy in a new head-to-head trial, though both medications ...
Zacks Investment Research on MSN23h
3 Stocks Targeting Weight Loss Market With Cannabinoid-Based Therapies
The obesity market has garnered much interest lately, propelled by the success of GLP-1 therapies Wegovy and Zepbound, marketed by pharma giants Novo Nordisk NVO and Eli Lilly LLY, respectively. This ...
Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests
Researchers are beginning to wonder whether blockbuster drugs such as Wegovy, Ozempic and Zepbound could play a role in ...